U.S. markets closed
  • S&P Futures

    4,314.25
    -27.25 (-0.63%)
     
  • Dow Futures

    33,843.00
    -212.00 (-0.62%)
     
  • Nasdaq Futures

    14,058.25
    -100.25 (-0.71%)
     
  • Russell 2000 Futures

    1,955.80
    -16.90 (-0.86%)
     
  • Crude Oil

    87.22
    -0.13 (-0.15%)
     
  • Gold

    1,816.10
    -13.60 (-0.74%)
     
  • Silver

    23.42
    -0.38 (-1.60%)
     
  • EUR/USD

    1.1235
    -0.0010 (-0.09%)
     
  • 10-Yr Bond

    1.8480
    +0.0650 (+3.65%)
     
  • Vix

    31.96
    +0.80 (+2.57%)
     
  • GBP/USD

    1.3452
    -0.0011 (-0.08%)
     
  • USD/JPY

    114.5920
    -0.0680 (-0.06%)
     
  • BTC-USD

    36,287.89
    -449.76 (-1.22%)
     
  • CMC Crypto 200

    826.94
    -28.87 (-3.37%)
     
  • FTSE 100

    7,469.78
    +98.32 (+1.33%)
     
  • Nikkei 225

    26,611.27
    -400.06 (-1.48%)
     

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • TNDM

SAN DIEGO, October 28, 2021--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences:

  • Credit Suisse 30th Annual Virtual Healthcare Conference on Tuesday, November 9, 2021 at 12:10pm Eastern Time (9:10am Pacific Time), and

  • Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17, 2021 at 4:00pm Eastern Time (1:00pm Pacific Time).

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005861/en/

Contacts

Media Contact:
Steve Sabicer
714-907-6264
ssabicer@thesabicergroup.com

Investor Contact:
Susan Morrison
858-366-6900
IR@tandemdiabetes.com